Current Opinion in Virology

Papers
(The TQCC of Current Opinion in Virology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board51
A novel antiviral strategy by disrupting the equilibrium of virus-host calcium homeostasis50
Inhaled aerosol viral-vectored vaccines against tuberculosis38
Transmission patterns of hepatitis E virus35
Hepatitis-B virus: replication cycle, targets, and antiviral approaches35
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-1934
The enigmatic roles of Anelloviridae and Redondoviridae in humans34
Colonization of peripheral ganglia by herpes simplex virus type 1 and 231
Human placental models for studying viral infections30
Editorial Board30
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs27
Editorial overview: Viral pathogenesis25
Editorial Board24
Emerging technologies in the study of the virome23
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation23
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface22
A review of broadly protective monoclonal antibodies to treat Ebola virus disease20
A complex immune communication between eicosanoids and pulmonary macrophages20
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity20
Asymmetry in icosahedral viruses19
The enigma of picobirnaviruses: viruses of animals, fungi, or bacteria?19
Editorial Board18
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities18
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?18
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases17
Tissue-resident memory T cells in protective immunity to influenza virus17
Hemagglutinin stability as a key determinant of influenza A virus transmission via air17
Oncogenic Animal Herpesviruses17
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity17
Retasking of canonical antiviral factors into proviral effectors17
Human organoid models to study coronavirus infections of the respiratory tract17
Deimmunization of flagellin adjuvant for clinical application16
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions16
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications16
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection16
Role of the viral polymerase during adaptation of influenza A viruses to new hosts16
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 515
Diagnosis and monitoring of virus-associated cancer using cell-free DNA15
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy15
0.087040185928345